Workflow
Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
CARAvis Budget Group(CAR) Prnewswire·2024-09-17 11:00

PHILADELPHIA, Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a 150,000G−RexGrantbyScaleReady™.ThisgrantwillsupportVerismoTherapeutics′ongoingeffortstooptimize thedevelopmentandmanufacturingofitsKIR−CARplatformusingtheG−Rex. TheG−RexGrantispartofScaleReady′s150,000 G-Rex Grant by ScaleReady™. This grant will support Verismo Therapeutics' ongoing efforts to optimize the development and manufacturing of its KIR-CAR platform using the G-Rex. The G-Rex Grant is part of ScaleReady's 20 million grant program aimed at advancing Cell and Gene Therapy (CGT) development and manufa ...